Back
Enliven Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
ELVN
Enliven Therapeutics, Inc.
Last Price:
$38.72
Seasonality Move:
9.15%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ELVN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Enliven Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.15 | Buy |
| 20-day SMA: | 32.31 | Buy |
| 50-day SMA: | 29.46 | Buy |
| 200-day SMA: | 22.61 | Buy |
| 8-day EMA: | 36.75 | Buy |
| 20-day EMA: | 33.58 | Buy |
| 50-day EMA: | 29.82 | Buy |
| 200-day EMA: | 24.14 | Buy |
Enliven Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.85 | Buy |
| Relative Strength Index (14 RSI): | 67.83 | Buy |
| Chaikin Money Flow: | 772744 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.65 - 35.83) | Buy |
| Bollinger Bands (100): | (18.88 - 30.72) | Buy |
Enliven Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Enliven Therapeutics, Inc. Stock
Is Enliven Therapeutics, Inc. Stock a Buy?
-
Enliven Therapeutics, Inc. share price is 38.83 while ELVN 8-day simple moving average is 37.15, which is a Buy signal.
-
The stock price of ELVN is 38.83 while Enliven Therapeutics, Inc. 20-day SMA is 32.31, which makes it a Buy.
-
Enliven Therapeutics, Inc. 50-day simple moving average is 29.46 while ELVN share price is 38.83, making it a Buy technically.
-
ELVN stock price is 38.83 and Enliven Therapeutics, Inc. 200-day simple moving average is 22.61, creating a Buy signal.
ELVN Technical Analysis vs Fundamental Analysis
Sell
47
Enliven Therapeutics, Inc. (ELVN)
is a Sell
Is Enliven Therapeutics, Inc. a Buy or a Sell?
-
Enliven Therapeutics, Inc. stock is rated a SellThe current Enliven Therapeutics, Inc. [ELVN] share price is $38.83. The Score for ELVN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Enliven Therapeutics, Inc. Stock Info
Market Cap:
2.4B
Price in USD:
38.83
Share Volume:
810.9K
Enliven Therapeutics, Inc. 52-Week Range
52-Week High:
40.62
52-Week Low:
13.30
Sell
47
Enliven Therapeutics, Inc. (ELVN)
is a Sell
Enliven Therapeutics, Inc. Share Price Forecast
-
What is the Enliven Therapeutics, Inc. stock price today?The Enliven Therapeutics, Inc. stock price is 38.83 USD today.
-
Will ELVN stock go up or go down?Enliven Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Enliven Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Enliven Therapeutics, Inc. is overvalued.
Is Enliven Therapeutics, Inc. Stock a Buy?
-
Enliven Therapeutics, Inc. share price is 38.83 while ELVN 8-day exponential moving average is 36.75, which is a Buy signal.
-
The stock price of ELVN is 38.83 while Enliven Therapeutics, Inc. 20-day EMA is 33.58, which makes it a Buy.
-
Enliven Therapeutics, Inc. 50-day exponential moving average is 29.82 while ELVN share price is 38.83, making it a Buy technically.
-
ELVN stock price is 38.83 and Enliven Therapeutics, Inc. 200-day simple moving average is 24.14, creating a Buy signal.
Fundamental Analysis of Enliven Therapeutics, Inc.
Is Enliven Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and a decrease next year of $0.60 per share.
Technical Analysis of Enliven Therapeutics, Inc.
Should I short Enliven Therapeutics, Inc. stock?
-
ELVN Moving Average Covergence Divergence (MACD) indicator is 2.85, suggesting Enliven Therapeutics, Inc. is a Buy
-
Enliven Therapeutics, Inc. Relative Strength Index (RSI) is 67.83, which suggest Enliven Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Enliven Therapeutics, Inc. is (27.65 - 35.83), which suggest Enliven Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Enliven Therapeutics, Inc. is (18.88 - 30.72), which suggest Enliven Therapeutics, Inc. is a Buy
* Enliven Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.